New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 3, 2014
12:10 EDTBKS, LMCA, C, AMRS, LQDT, VVUS, RPMOn The Fly: Midday Wrap
Stocks on Wall Street began the session in positive territory, with the Dow notching a new all-time high, but had slid into negative ground at midday. The Nasdaq is the biggest loser, as it is down more than 0.6%, while the Dow and Nasdaq are just slightly below the flat line. ECONOMIC EVENTS: In the U.S., initial jobless claims rose to 326K in the week ended March 29, versus the expected 319K claims. The trade deficit widened to $42.3B in February from a revised $39.3B deficit in January. ISM's non-manufacturing PMI rose 1.5 points to 53.1 in March, though that was a bit below the 53.5 forecast of economists. In Europe, the ECB maintained its current rates despite the ongoing debate over disinflationary forces posing an increasing risk. In Asia, China's State Council announced a stimulus package for new railways and subways, low-income housing and tax breaks for small business, but most of the measures were part of the government's previously communicated annual economic work plan. COMPANY NEWS: Shares of Barnes & Noble (BKS) are declining after Liberty Media (LMCA) announced a deal to reduce its stake in the bookseller. Liberty said it has sold the majority of its shares to institutional buyers and will retain approximately 10% of its initial investment, which has been reported to equate to a roughly 2% stake in Barnes & Noble. B&N Chairman Leonard Riggio said that Liberty’s reduced ownership gives the company greater flexibility to pursue various strategic options, but shares of B&N slid 13% following the announcement... Citigroup (C) shares fell almost 2% after The New York Times said the federal government has started a criminal investigation into alleged fraud involving Citi's Banamex unit in Mexico. Also of note, research firm Sterne Agee downgraded the stock to Neutral, citing the Fed's refusal to approve the bank's capital plan, along with its slowing earnings growth and lack of catalysts, as reasons for the downgrade. MAJOR MOVERS: Among the notable gainers was Amyris (AMRS), which rose 8% after announcing that it is entering into a strain engineering research and development agreement with chemical giant BASF (BASFY). Also higher was chemical, paint, and coating maker RPM (RPM), which gained 4% and hit a fresh 52-week high earlier in the session after the company raised its fiscal 2014 profit outlook. Among the noteworthy losers was Liquidity Services (LQDT), which slid another 12% after the company confirmed it's withdrawal from auction bidding for a U.S. Department of Defense contract and said it will need to reset its adjusted earnings expectations. Also lower were shares of weight-loss drug maker VIVUS (VVUS), which fell nearly 8% following a downgrade to Underweight at Piper Jaffray. INDEXES: Near midday, the Dow was down 16.31, or 0.1%, to 16,556.69, the Nasdaq was down 26.65, or 0.62%, to 4,249.81, and the S&P 500 was down 3.48, or 0.18%, to 1,887.42.
News For BKS;LMCA;C;AMRS;LQDT;VVUS;RPM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 25, 2014
12:17 EDTRPMH.B. Fuller plummets to 52-week low after results, outlook trail estimates
Shares of H.B. Fuller (FUL), which manufactures adhesives, sealants and other specialty chemical products, are sinking after the company's third quarter results and fourth quarter profit outlook missed analysts' consensus estimates. WHAT'S NEW: Last night, H.B. Fuller reported Q3 adjusted earnings per share of 42c and revenue of $526.8M, significantly trailing analysts' consensus estimates of 76c and $539.54M, respectively. The company forecast Q4 adjusted EPS of 60c-70c, far below the consensus of 85c. H.B. Fuller increased its fiscal year 2014 CapEx view to $135M from $105M. WHAT'S NOTABLE: H.B. Fuller CEO Jim Owens said, "The delayed and costly execution of our SAP project in North America and European business integration project led to disappointing and unacceptable results this quarter. We took decisive actions to accelerate the completion of our major projects and move to normal operating conditions. More work is to be done in the fourth quarter, but we expect our intensified focus on completing these projects will lead to improved operating performance in the fourth quarter and pave the way for a strong 2015, putting us back on track to achieve our long term goals of 15% EBITDA margin and solid organic growth." On its conference call, management confirmed the 15% EBITDA margin goal, but said it will be delayed at least one year. They expect "significant" improvements in Q4, and FY15, and noted that recent challenges have been project related and can easily be fixed. They expect to launch the Latin America business in mid-2015. PRICE ACTION: In early afternoon trading, H.B. Fuller fell $5.44, or about 12.37%, to $38.54 on over seven times its average daily trading volume. Earlier in the session, the stock notched a fresh 52-week low of $36.92. Including today's pull-back, the shares have lost almost 5% over the past 12 months. OTHERS TO WATCH: Other companies in the sealants and chemicals space include Sherwin-Williams (SHW), The Valspar Corporation (VAL), and RPM International (RPM).
September 24, 2014
15:04 EDTCGoldman, other banks near deal to buy Bloomberg messaging alternative, WSJ says
Subscribe for More Information
09:34 EDTCActive equity options trading on open
Subscribe for More Information
September 23, 2014
16:00 EDTCOptions Update; September 23, 2014
Subscribe for More Information
10:17 EDTAMRSAmyris rises after reporting KLM plans use of renewable jet fuel
Shares of Amyris (AMRS) are rising in early trading after the company stated on its corporate Twitter account last night that KLM intends to use a renewable jet fuel from Amyris and Total (TOT). Shares of Amyris are up 4% to $4.10 in early trading following last night's Tweet from the company. Reference Link
07:33 EDTCCitigroup threatened by Argentina over bond payments, Reuters reports
Argentine Economy Minister Axel Kicillof threatened Citigroup with "penalties" if the bank failed to make a $5M interest payment due to bondholders by Sept. 30 and the bank plans to ask a U.S. judge to stay an order barring it from processing payments on $8.4B in bonds issued after the country's 2002 default, reported Reuters. Reference Link
September 22, 2014
16:00 EDTCOptions Update; September 22, 2014
iPath S&P 500 VIX Short-Term Futures up 91c to 28.14. Option volume leaders: AAPL TSLA NFLX C TWTR AMZN BP PBR CLF WLT according to Track Data.
09:38 EDTCActive equity options trading on open
Subscribe for More Information
September 20, 2014
21:15 EDTCCitigroup and Argentina's appeal on bond case dismissed, Reuters says
Subscribe for More Information
September 19, 2014
11:14 EDTCSumitomo Mitsui, Mitsubishi UFJ on short list for Citigroup unit, WSJ reports
Sumitomo Mitsui Financial Group (SMFG), Sumitomo Mitsui Trust Holding, Mitsubishi UFJ Financial (MTU) and Shinsei Bank have been shortlisted by Citigroup (C) as buyers for the U.S. bank's retail bank in Japan, the Wall Street Journal reports, citing sources. Citi could pick a buyer for the unit by the end of the year or early next year. Citigroup could sell its Diners Club branded credit card unit in Japan along with the retail bank, a source says. Reference Link
09:37 EDTCActive equity options trading on open
Subscribe for More Information
07:17 EDTCCitigroup up against hard situation in Argentina bond plea, Reuters says
Subscribe for More Information
September 18, 2014
16:27 EDTVVUSOn The Fly: Closing Wrap
Subscribe for More Information
14:09 EDTVVUSVIVUS rallies, mean-reverting to intraday trend line
The shares have traded in an extremely wide range today on nearly 20 times daily average volume. An intraday trend line appears currently to be broken. That line is at $4.60 now, and projecting forward would be at the $4.80 area by the close. At the current price of $4.50, support is at $4.41 and then at $4.32.
14:08 EDTCBanks look to high-interest personal loans to boost revenue, WSJ says
Subscribe for More Information
12:45 EDTVVUSOn The Fly: Midday Wrap
Subscribe for More Information
09:36 EDTVVUSActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL YHOO TWTR VVUS RAD PWE WFM TSLA PIR SHLD
08:59 EDTVVUSOn The Fly: Pre-market Movers
Subscribe for More Information
06:05 EDTVVUSVIVUS, Auxilium announce FDA approval of STENDRA sNDA
VIVUS (VVUS) and Auxilium Pharmaceuticals (AUXL) announced that the FDA has approved a supplemental new drug application, or sNDA, for STENDRA. STENDRA is now the only FDA-approved erectile dysfunction, or ED, medication indicated to be taken as early as approximately 15 minutes before sexual activity. STENDRA is a prescription medication in a class of drugs known as phosphodiesterase type 5, or PDE5, inhibitors approved for the treatment of ED in men 18 years or older. STENDRA is available in multiple dosage strengths and may be taken with or without food and moderate alcohol consumption. In clinical studies, when compared to placebo, STENDRA helped more men achieve an erection in as early as approximately 15 minutes that lasted long enough to successfully complete sexual intercourse.
05:28 EDTBKSBarnes & Noble NOOK Press partners with The Bookseller
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use